Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pharmacol Biochem Behav ; 209: 173257, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34418452

RESUMEN

Metoprine increases the content of histamine in brain by inhibiting histamine N-methyltransferase (HMT), a centrally acting histamine degrading enzyme. We present data demonstrating that pretreatment with metoprine attenuates the hyperlocomotive effects of METH in mice using a multi-configuration behavior apparatus designed to monitor four behavioral outcomes [horizontal locomotion, appetitive behavior (food access), and food and water intake]. Metoprine pretreatment itself induced hyperlocomotion in mice challenged with saline during the large part of light phase. The trend was also observed during the following dark phase. This is the first report that metoprine has a long-lasting locomotor stimulating property. Similarly, in a tail suspension test, a single injection of metoprine significantly reduced total time of immobility in mice, consistent with the idea that metoprine possesses motor stimulating properties. Metoprine pretreatment did not affect other aspects of behavior. Metoprine did not affect the appetitive and drinking behavior while exerted an effect on stereotypy. No stereotyped behavior was observed in mice pretreated with vehicle followed by METH, while stereotyped sniffing was observed in mice pretreated with metoprine followed by METH. The metoprine pretreatment attenuated METH-induced hyperlocomotion during the first 2 h of light phase, suggesting that metoprine-induced locomotor stimulating property might be different from that of METH. The hypothalamic content of histamine (but not its brain metabolite) was increased after metoprine or METH administration. Both METH and metoprine reduced dopamine and histamine turnover in the striatum and the nucleus accumbens and the hypothalamus, respectively, and there is a significant metoprine pretreatment x METH challenge interaction in the histamine turnover. It is likely that metoprine may attenuate METH-induced hyperlocomotion via activation of histaminergic neurotransmission. Metoprine also might induce a long-lasting locomotor stimulating effect via a putative mechanism different from that whereby METH induces the locomotor stimulating effect.


Asunto(s)
Histamina/metabolismo , Locomoción/efectos de los fármacos , Metanfetamina/farmacología , Pirimetamina/análogos & derivados , Transmisión Sináptica/efectos de los fármacos , Animales , Conducta Animal/efectos de los fármacos , Dopamina/metabolismo , Inhibidores Enzimáticos/farmacología , Conducta Alimentaria/efectos de los fármacos , Histamina N-Metiltransferasa/antagonistas & inhibidores , Hipotálamo/metabolismo , Masculino , Metanfetamina/efectos adversos , Ratones , Ratones Endogámicos ICR , Núcleo Accumbens/metabolismo , Pirimetamina/farmacología , Conducta Estereotipada/efectos de los fármacos
2.
Brain Res ; 1768: 147580, 2021 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-34260963

RESUMEN

Kamishoyosan (KSS), a Japanese traditional herbal formula, is used to treat symptoms related to the autonomic nervous system in men and women; it is especially known for improving the symptoms of irritability (e.g., bad temper and persistent anger). Although clinical and ethological studies of KSS have been conducted, its efficacy in reducing irritability remains to be validated. In the present study, male and female ddY-strain mice were isolation-reared for 8 weeks (from the third postnatal week) to induce pathologically aggressive biting behavior (ABB), which was used as an indicator of irritability. The ABB of mice toward metal rods was measured using the Aggressive Response Meter. An intraperitoneal administration of KSS (100 mg/kg) effectively reduced ABB in male and female mice at 2 h after the administration; however, this effect was canceled by prior administration of WAY-100635 [a 5-hydroxytryptoamine (5-HT)-1A receptor antagonist; 0.5 mg/kg] and bicuculline (a type-A gamma-aminobutyric acid receptor antagonist; 1.0 mg/kg). Additionally, tamoxifen, ICI-182780, and G-15 (all estrogen receptor antagonists) inhibited the action of KSS in a dose-dependent manner. Furthermore, gene expression of tryptophan hydroxylase (Tph) 1 and Tph2 were increased and 5-HT immunofluorescence was slightly increased in the dorsal raphe nucleus (DRN) of isolation-reared mice administered with KSS. Collectively, these results indicate that KSS effectively reduces ABB in isolation-reared male and female mice through stimulation of 5-HT production in the DRN. Our findings also suggest that gene expression of estrogen receptor (Esr) 2 increased in the DRN might be associated with the reduction of ABB.


Asunto(s)
Agresión/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Genio Irritable/efectos de los fármacos , Animales , Núcleo Dorsal del Rafe/metabolismo , Medicamentos Herbarios Chinos/metabolismo , Receptor beta de Estrógeno/metabolismo , Femenino , Expresión Génica/genética , Japón , Masculino , Medicina Tradicional China/métodos , Ratones , Ratones Endogámicos , ARN Mensajero/metabolismo , Serotonina/metabolismo , Aislamiento Social , Transcriptoma/efectos de los fármacos , Triptófano Hidroxilasa/metabolismo
3.
J Psychopharmacol ; 21(7): 757-67, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17606472

RESUMEN

Although the mechanism of action of acetaminophen (AAP) is not fully understood, some studies suggest that AAP and phenacetin (PHE) are selective cyclooxygenase (COX)-3 inhibitors. To examine the participation of COX-3 in memory formation, water maze performance was studied in mice treated with AAP, PHE or other COX inhibitors. Mice received intraperitoneal injections of drugs immediately after each training session. Administration of high-dose AAP [302.3 mg/kg (IC50 for COX-2)] or PHE [179.2 mg/kg (IC50 for COX-2)] and of non-specific (indomethacin: 20 mg/kg) or specific COX-2 (NS-398: 10 mg/kg) inhibitor impaired the performance in hidden platform (HP) not visible platform (VP) tasks, whereas low-dose (15.1 mg/kg) AAP facilitated performance in HP and VP tasks. The facilitation of performance by low-dose AAP was reversed by co-administration with a 5-HT(1/2) receptor antagonist (methysergide: 0.47 mg/kg). The middle-dose [69.5 mg/kg (IC50 for COX-3)] of AAP, the PHE [17.9 mg/kg (IC50 for COX-3)] and a specific COX-1 inhibitor (piroxicam: 10-20 mg/kg) did not influence performance in either task. These results suggest that the memory impairment by high-dose AAP and PHE and facilitation of performance by low-dose AAP could involve endogenous COX-2 and serotonergic neuronal activity, but not COX-3, respectively.


Asunto(s)
Acetaminofén/farmacología , Inhibidores de la Ciclooxigenasa/farmacología , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/fisiología , Prostaglandina-Endoperóxido Sintasas/metabolismo , Acetaminofén/administración & dosificación , Animales , Ciclooxigenasa 1/metabolismo , Ciclooxigenasa 2/efectos de los fármacos , Ciclooxigenasa 2/metabolismo , Inhibidores de la Ciclooxigenasa 2/administración & dosificación , Inhibidores de la Ciclooxigenasa 2/farmacología , Inhibidores de la Ciclooxigenasa/administración & dosificación , Relación Dosis-Respuesta a Droga , Concentración 50 Inhibidora , Inyecciones Intraperitoneales , Masculino , Memoria/efectos de los fármacos , Metisergida/farmacología , Ratones , Fenacetina/administración & dosificación , Fenacetina/farmacología , Prostaglandina-Endoperóxido Sintasas/efectos de los fármacos , Antagonistas de la Serotonina/farmacología
4.
Anal Sci ; 18(10): 1145-50, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12400663

RESUMEN

Using a portable near infrared (NIR) spectrometer, we discriminated flours for making Japanese noodles (Soba), not only relying on a statistical and mathematical approach, but also on a chemical interpretation of the NIR spectra. In original NIR spectra, the particle-size difference, which results in an undesired systematic variation, was extracted and interpreted as the first-principal component factor by a principal-component analysis. The discrimination of flour materials cannot be satisfied by this factor. However, after a standardized treatment for the original spectra, the particle-size effects were eliminated; alternatively, differences in the chemical contents were extracted as principal-component factors. Using these factors, flour material discrimination was achieved much better. This study suggests a novel idea of utilizing the wavelength contribution ratio spectra for interpreting the factors extracted from the principal-component analysis for the NIR spectra. This report also describes the relationship between the NIR spectra and the chemical-analysis data.


Asunto(s)
Harina/análisis , Análisis de los Alimentos/métodos , Espectrofotometría Infrarroja/métodos , Fagopyrum/química , Tamaño de la Partícula , Sensibilidad y Especificidad , Programas Informáticos , Triticum/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA